.png)
.webp)
R. David Yost was key to Cencora’s success through a 37-year career that culminated in his 14-year tenure as CEO.
He oversaw the $7 billion merger of AmeriSource Health Corp. and Bergen Brunswig in 2001, which eventually became the Cencora brand.
As the first CEO of Cencora, Yost built competitive positions in pharmaceutical distribution services, specialty pharmaceuticals, and generics distribution.
He implemented cost-management practices and customer-centric operational models to fuel growth.
His leadership ended on July 1, 2011, at age 63, when he stepped down from both the CEO position and board membership.
Though retired, he still maintains significant holdings in Cencora, valued above $366 million as of 2024.
Steven H. Collis served as CEO of Cencora from 2011 to 2024.
He drove the company’s revenue from $80 billion to over $250 billion.
During his tenure, Cencora’s workforce grew to over 46,000 employees across 50 countries.
Collis oversaw three key acquisitions:
Collis also engineered a groundbreaking partnership with Walgreens Boots Alliance, creating the first instance of a national pharmacy chain outsourcing its pharmaceutical distribution to a wholesaler.
The company achieved a net income of $1.75 billion by 2023, earning consecutive top rankings on Barron’s 500 list in 2016 and 2017.
The Wall Street Journal recognized Collis as Philadelphia’s top-performing CEO in 2015, and he received the Healthcare Distribution Alliance’s Nexus Award for Lifetime Achievement in 2024.
Robert P. Mauch’s appointment as President and CEO of Cencora marks a significant leadership transition in the history of the company.
A pharmacist by training with both a Pharm.D. and Ph.D., Mauch joined Cencora in 2007 through its acquisition of Xcenda, the health economics firm he founded.
His ascent through Cencora’s ranks includes positions as Chief Operating Officer, Executive Vice President, and President of AmerisourceBergen Drug Corporation.
The October 1, 2024 succession plan installs Mauch as only the third CEO in the company’s 23-year history.
Mauch brings direct operational experience leading Cencora’s domestic and international business units, along with substantial ownership stake valued at $12.86 million and annual compensation of $7.70 million.
.png){kind=logo}
.webp)
.webp)
.webp)